Israeli developer of advanced GI screening systems GI View Ltd. has received US Food and Drug Administration (FDA) 510(k) clearance for its Aer-O-Scope Colonoscope System. Aer-O-Scope is a disposable, self-propelled, joystick-controlled, easy-to-use colonoscope system, with therapeutic access. The new system has two working channels that enable therapeutic access using standard tools, such as snares and forceps, to take biopsies or perform polypectomies.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The Aer-O-Scope is the first colonoscope to provide a 360° omni-directional visualization of the colon to detect polyps behind folds. There is also no risk of contamination or disease transmission between patients from the device as it is to be used only once and then disposed. The Aer-O-Scope employs a soft multi-lumen tube designed to significantly reduce pressure on the colon wall, which in turn, increases patient safety. The tube is also hydrophilic, which reduces the friction between bowel and scope by more than 90%. Patient safety and comfort as well as physician ease of use are further maximized by the system’s self-propelled intubation, created using balloons and low pressure CO2 gas. As the system is joystick controlled it is also extremely simple to operate and requires minimal training. Like all colonoscopes, the Aer-O-Scope provides insufflation, irrigation and suction.
Colorectal cancer is one of the biggest causes of cancer death in most countries in the West. This type of cancer can almost always be prevented by early detection and removal of polyps, which if left untouched, can develop into colorectal cancer over a 5-10 year period. More than 690, 000 people worldwide die from colorectal cancer annually.